302,00 € excl.VAT – 2.028,00 € excl.VAT
The VU-1D9 monoclonal antibody reacts with the human CD326 is also known as Ep-CAM, tumor associated calcium signal transducer 1, epithelial cell surface antigen, epithelial glycoprotein 2, EGP2, adenocarcinoma associated antigen, and TROP1. This cell surface glycosylated 40 kD protein is highly expressed in bone marrow, colon, lung, and most normal epithelial cells and is expressed on carcinomas of gastrointestinal origin. Recently, it has been reported that CD326 expression occurs during the early steps of erythrogenesis. CD326 functions as a homotypic calcium-independent cell adhesion molecule and is believed to be involved in carcinogenesis by its ability to induce genes involved in cellular metabolism and proliferation. CD326 antigen is an immunotherapeutic target for the treatment of human carcinomas is a type I transmembrane protein containing six disulfide bridges and one THYRO domain.
Conjugated | |
---|---|
Size | |
Regulatory Status | |
Clone | |
Gene ID | |
Format | |
Species Reactivity | |
Isotype | |
Tested Applications | |
Clonality | |
UniProt | |
Mw | |
Population | |
Volume | 1 mg/ml, 1 μg/test, 20 μL/test |
Almacenamiento | Store in the dark at 2-8°C. |
Otros nombres | EpCAM. |
Buffer | The reagent is provided in aqueous buffered solution containing protein stabilizer, and ≤0.09% sodium Azide (NaN3). |
Immunogen | Human small cell lung carcinoma cell line NCl-H69. |
Concentración | 0,01 mg/ml, 2 mg/ml |
CD326, clone VU-1D9, is a mAb intended for the identification of bone marrow, colon, lung, and most normal epithelial cells. Also highly expressed on carcinomas of gastrointestinal origin. Expressed during early erythrogenesis. This reagent is effective for direct IF staining of human tissue for FCM analysis using ≤1 μg/10^6 cells.
Product description | Reference | Title | Authors | Journal | Year | |
---|---|---|---|---|---|---|
Product description | Reference | Title | Authors | Journal | Year |